Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, indigestion is a recognised side effect of Wegovy (semaglutide). It appears in the medicine's clinical data and its licensed prescribing information, most commonly in the early weeks of treatment or after a dose increase. The medical term is dyspepsia — a burning or uncomfortable sensation in the upper stomach, often accompanied by bloating or reflux — and it tends to ease as your body adjusts. These are the digestive effects Wegovy is most associated with, and understanding why they happen makes them considerably less alarming. Wegovy is a prescription-only medicine; suitability and how to manage any side effects is something a prescriber works through with you personally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people starting Wegovy assume that gut discomfort signals something going wrong, that their stomach is being irritated, inflamed, or harmed in some way. That's understandable, but it isn't what's happening. Wegovy works partly by slowing the rate at which your stomach empties. Food sits in the upper digestive tract a little longer than usual, which is one of the reasons you feel full sooner and eat less. The price of that mechanism, for many people, is that the same stomach can feel fuller and more pressured than it's used to, producing that familiar burning or heavy sensation after eating.
This is a physiological response to how the medicine works, not a sign of injury. The NHS medicine information for semaglutide lists indigestion among the side effects affecting more than one in ten people, placing it firmly in the 'common' category. It also notes that most gut-related effects are most pronounced in the first few weeks of each new dose and typically improve without any change to treatment.
If you're reading this in week two of starting Wegovy and wondering whether to stop, you're far from alone. Many people reach this point. The answer, generally, is to give your system time, and to speak to your prescriber before making any decisions about your treatment.
Dyspepsia on semaglutide can show up in a few different ways: a burning sensation in the upper abdomen or behind the breastbone, a feeling of uncomfortable fullness during or after meals, excessive belching (burping is a side effect worth its own explanation), or a general sense of pressure in the stomach, and gas is another symptom that many people on Wegovy find themselves dealing with. Occasionally it overlaps with acid reflux, particularly when lying down after eating.
Eating habits that were perfectly fine before starting Wegovy can suddenly feel too much. Large portions, fatty or rich meals, eating quickly, and lying down soon after eating all tend to intensify the discomfort. Carbonated drinks can make it noticeably worse. Most people find that smaller, slower meals (leaning towards plain foods during the adjustment period) reduce the frequency and severity considerably. This isn't a dietary restriction the medicine imposes permanently; it's a practical response to a temporary phase of adjustment.
Dose increases are the other common trigger. The titration schedule for Wegovy moves from a low starting dose upward over several months, and each step can briefly reintroduce the gut symptoms that had settled. That's expected and is built into the design of the dose schedule. You can read more about how Wegovy's side effects are generally managed alongside the titration process.
Ordinary dyspepsia on Wegovy is uncomfortable but not dangerous. The signs that it has become something else entirely are specific and worth knowing clearly.
Seek medical help promptly if you experience severe pain in the upper abdomen that does not pass, especially if that pain spreads or radiates to your back, with or without vomiting. This pattern can indicate acute pancreatitis, a known but infrequent side effect of GLP-1 medicines including semaglutide. The MHRA highlighted acute pancreatitis in its January 2026 Drug Safety Update on GLP-1 medicines, underscoring that any symptom fitting this description warrants urgent assessment rather than watchful waiting.
Other symptoms that need prompt attention include: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing, rapid heartbeat); severe dehydration from persistent vomiting or diarrhoea (dizziness, very dark urine, inability to keep fluids down); or any new symptom that feels qualitatively different from the background digestive grumbling you've been managing. If something feels wrong, it's always right to contact a doctor or call 111.
If your symptoms are manageable but persistent, that's a conversation for your prescriber, not a reason to push through quietly. You can also report any suspected side effect, including indigestion you feel is severe or unusual, via the MHRA Yellow Card scheme, which helps regulators monitor medicines in real-world use.
At nume, every person starting Wegovy has their consultation personally reviewed by a GPhC-registered Independent Prescriber, a real clinician reading your answers and medical history, not automated software. Part of that assessment includes your existing digestive health: conditions like pre-existing reflux, gastritis or certain gut disorders affect whether Wegovy is appropriate and how closely you should be monitored early on.
Side effects, including indigestion, are part of what that clinical conversation covers. If you're already on treatment and struggling, our prescribers can discuss practical approaches and review whether anything about your plan needs adjusting. That support continues after your first order; our aftercare team is available seven days a week. If you haven't started yet and want to understand your suitability (including how likely you are to experience digestive side effects based on your history) a free consultation with our prescribers is the first step. There's no obligation, and no fee for the assessment itself. For a broader look at Wegovy and how it works, the Wegovy overview page covers the essentials, and the full side-effect picture goes into more detail beyond the gut.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.